Skip to main content
reMYND reMYND reMYND
  • Home
  • Platform & products
      • Lead Alzheimer program ReS19-T
      • Huntington program ReS18-H
      • Orphan programs
  • Services
      • APP-London model
      • APPxPS1 model
      • Tau[P301L] model
      • Tau[P301S] model
      • APP[V717I]xTau[P301L] model
      • APP[V717I]xTau[P301S] model
      • Seed and spread Tauopathy model
  • About us
      • People
      • News
          • reMYND’s novel Alzheimer program reports excellent brain exposure and safety profile in Phase 1; transitioning into Phase 2a
          • reMYND’s ReS19-T program, managing calcium homeostasis for Alzheimer’s, has moved to MAD phase after demonstrating strong safety in SAD phase
          • reMYND identifies novel target and small molecules with potential to halt and reverse disease progression in Huntington’s disease through oral administration
          • reMYND extends Series B funding to EUR 24 million
          • reMYND commences first-in-human trial of ReS19-T Alzheimer’s program
          • reMYND appoints Dr. Lode Debrabandere as Chief Business Officer
          • reMYND announces Clinical Advisory Board to support development of Alzheimer’s programme
          • reMYND and the US NINDS Epilepsy Therapy Screening Program (ETSP) begin collaboration on epilepsy program
          • Interreg. project "Memories" update
          • Interreg. project "Memories" holds 2nd annual symposium & new newsletter is available
          • Approved project ‘Memories’ (‘Herinneringen’ in Dutch): early diagnostics of Alzheimer’s disease (AD)
      • Partners
  • Jobs
      • Research Associate
      • Quality Associate
  • Contact

Research Associate

  • Home
  • /
  • Jobs
  • /
  • Research Associate
PDF icon Research Associate 2022-.pdf (164.8 KB)

Jobs

  • Quality Associate
  • Research Associate
  • Home
  • Platform & products
  • Services
  • About us
  • Jobs
  • Contact

Partners

Alt
Alt
Alt
Alt
Alt
Alt
Alt
Alt
vlaio
Flandersbio
Interreg Vlaanderen Nederland
Alt
Eureka

CRO News Flashes

Subscribe Inline

Contact

reMYND, Bio-Incubator (Wetenschapspark)
Gaston Geenslaan 1
BE-3001 Leuven (Heverlee)
Belgium

RPR Leuven, 0476.910.101
BTW/VAT: BE0476.910.101

T +32 16 75 14 20
F +32 16 75 14 21
info@remynd.com

Terms & conditions